Clostridioides difficile Toxin Assay: Nursing Guide
The C. difficile toxin assay detects toxin A and/or B in diarrheal stool when healthcare-associated diarrhea is suspected — especially after recent antibiotics. Nurses often spot loose stools first, verify that testing criteria are met, collect valid specimens without transport media, initiate contact precautions when CDI is suspected, and avoid test-of-cure orders that can mislead recovery planning.
Contents
Quick Facts
Key Takeaway
A C. difficile toxin assay is only meaningful on the right stool from the right patient.
Specimen & Collection Details
Nurse quick-reference for collection prep that affects result quality.
Clean watertight stool container (not standard vacutainer)
No stool transport media — transport media may increase false-positive results per state health department guidance; follow institutional collection kit instructions
Unformed diarrheal stool in clean watertight container (per laboratory protocol)
Sufficient unformed stool to fill container per laboratory instructions — exact volume not specified as one universal standard in reviewed references
Only when clinically significant diarrhea is present (commonly defined as three or more unexplained unformed stools in 24 hours per CDC and CAP guidance); not for formed stool, asymptomatic screening, or routine test-of-cure
No fasting required for stool C. difficile toxin testing — focus on diarrheal criteria, laxative review, and prompt specimen handling
Transport to laboratory as soon as possible; refrigerate at 2–8 °C if immediate testing is delayed per public health guidance and laboratory guidance; do not freeze
Toxin enzyme immunoassay often returns within hours; full algorithm completion varies by laboratory — not specified as one universal time in reviewed references
Clinical microbiology / molecular diagnostics laboratory
What is Clostridioides difficile Toxin Assay?
Clostridioides difficile Toxin Assay is a laboratory test that detects toxins (usually toxin A and/or B) produced by toxigenic Clostridioides difficile in a stool sample. Enzyme immunoassay (EIA) is a common method with same-day results. A negative result means toxin was not detected in that specimen; a positive result means toxin was detected and may support a diagnosis of C. difficile infection when diarrhea and clinical findings align. Many laboratories use multistep algorithms combining toxin EIA with NAAT or GDH assays.
Overview
Nurses encounter C. difficile toxin orders when inpatients develop new diarrhea during or after antibiotics, with abdominal cramping, fever, or leukocytosis. CDC guidance emphasizes testing only patients with clinically significant diarrhea — typically three or more unexplained unformed stools in 24 hours. Bedside nurses often identify loose stools before physicians and may initiate nurse-driven testing protocols where policy allows.
Toxin testing is often paired with CBC and electrolytes when antibiotic-associated diarrhea is suspected. On this Tests & Diagnostics page, focus is indication, specimen validity, interpretation, contact precautions, and escalation — collection technique is covered in the Performance section below (Stool Specimen Collection procedure guide). Do not chart a confirmed CDI diagnosis from a single bedside result before the laboratory algorithm and prescriber complete interpretation.
Before collection: confirm diarrheal criteria, laxative use in the past 48 hours, and that formed stool is not being sent. After results: correlate toxin status with stool frequency, abdominal examination, WBC trend, and recent antibiotics. Initiate contact precautions per facility policy when CDI is suspected or confirmed. Escalate abdominal distension, ileus signs, or rising leukocytosis — not only the toxin line on the report.
Stool Specimen Validity and CDI Transmission Safety
C. difficile toxin results drive isolation and antimicrobial decisions — but inappropriate specimens, degraded toxin, or missed precautions can harm both the patient and roommates. Nurses protect patients by confirming diarrheal criteria, refrigerating stool promptly, avoiding test-of-cure, and initiating contact precautions when CDI is suspected.
- Positive toxin with abdominal distension, ileus signs, or toxic megacolon concern
- Suspected CDI with shared room and contact precautions not yet in place
- Specimen left at room temperature for prolonged periods — false-negative risk
- Test-of-cure or formed-stool orders that violate institutional testing criteria
Document: stool frequency and consistency, laxative and antibiotic history, collection and refrigeration times, precautions, toxin and reflex results, notifications, and treatment response.
What C. difficile Toxin Assay Can and Cannot Tell You
This test can help identify:
- C. difficile toxin A and/or B in diarrheal stool when clinical criteria are met
- Support for CDI diagnosis when symptoms, leukocytosis, and antibiotic exposure align
- Need for CDI treatment and contact precautions per prescriber and infection prevention plans
- Reflex molecular or antigen steps within a laboratory multistep algorithm
This test cannot:
- Diagnose CDI from formed stool, asymptomatic screening, or routine test-of-cure per CDC guidance
- Rule out CDI after one negative toxin if the specimen warmed or only standalone EIA was used
- Distinguish colonization from active disease when highly sensitive tests are used without clinical correlation
- Replace abdominal examination, imaging, or surgical review when severe colitis is suspected
Pre-collection Checks Before C. diff Stool Testing
Verify
Clarify before proceeding when:
- Only formed stool is available
- Patient had fewer than three unformed stools in 24 hours
- Routine laxatives or stool softeners used within 48 hours
- Order appears to be test-of-cure after completing therapy
- Repeat order within seven days of prior positive per institutional policy
- Specimen collected from toilet bowl or mixed with urine or soap
- Patient has ileus without diarrhea — discuss exception with prescriber and laboratory
Positive Toxin Results, False Negatives, and Clinical Correlation
Integrate toxin status with stool frequency, abdominal examination, WBC trend, hydration, and antibiotic timeline. CDC guidance toxin degrades quickly at room temperature; In practice, negative toxin alone may not exclude CDI when multistep testing or specimen handling is suboptimal.
| Clinical context | Pair with toxin result | Nursing focus |
|---|---|---|
| Watery diarrhea on antibiotics | Toxin positive | Contact precautions, notify prescriber, support CDI therapy and monitoring |
| Persistent diarrhea | Toxin negative on standalone EIA | Verify refrigeration; notify team for algorithm reflex or alternate diagnosis |
| Improving symptoms after therapy | Still positive on test-of-cure order | Clarify order — clinical recovery guides care, not repeat toxin per guidelines |
| Severe abdominal distension | Toxin positive or pending | Urgent escalation for complicated CDI evaluation regardless of pending reflex |
Reference ranges and critical values may vary by laboratory, institution, analyzer, age, sex, pregnancy status, and clinical context. Always interpret results using the reporting laboratory’s reference range and local escalation policy.
Loose-Stool Documentation and Specimen Traps at the Bedside
| Bedside point | Nursing note |
|---|---|
| Stool counts | Document number and consistency each shift — drives appropriate testing |
| Laxative review | Hold inappropriate testing if laxatives given within 48 hours per CAP screening questions |
| Container errors | No transport media; do not collect from toilet bowl |
| Temperature | Refrigerate within institutional time limits — toxin degrades at room temperature |
| Precautions delay | Do not wait for final NAAT to place contact precautions when CDI is likely |
| Hand hygiene | Soap and water after care — alcohol gel does not remove spores |
The clarify / hold rule
Clarify before proceeding when:
- Diarrheal criteria are not met but nurse-driven protocol triggered testing
- Order is test-of-cure or repeat within restricted interval
- Only formed stool is available for collection
- Specimen was in transport media or left unrefrigerated beyond policy
- Positive toxin on chart but patient has no diarrhea — verify result date
- Roommate remains in room after positive toxin without precautions
- Patient has worsening abdomen but team awaits toxin before escalation
C. diff Testing Workflow and Contact Precautions
Diagnostic safety badge: Critical-result test — positive toxin with severe symptoms or precaution delays require prompt review and escalation.
Check-before-test protocol
- Confirm diarrheal criteria and medication review
- Collect unformed stool per procedure guide
- Refrigerate or transport immediately with correct labeling
- Initiate contact precautions when CDI is suspected
- Notify prescriber for positive toxin or severe symptoms while results pending
Critical teach-back questions
- “Can you tell me why we are testing your stool for C. difficile?”
- “What symptoms should you report while we wait for results?”
- “Why is hand washing with soap and water important during your care?”
Care coordination: prescriber, microbiology laboratory, infection prevention, pharmacy, environmental services, and rapid response per institutional protocol.
C. diff Toxin Assay Quick Clinical Checklist
- Does the patient have at least three unformed stools in 24 hours without routine laxatives?
- Was stool collected promptly, without transport media, and kept cool?
- Are contact precautions in place when CDI is suspected or confirmed?
- Has a positive toxin been communicated and treatment supported?
- Do symptoms fit the result — or could handling, timing, or colonization explain discordance?
Why Clostridioides difficile Toxin Assay is Ordered
C. difficile toxin testing is ordered when clinicians suspect C. difficile infection (CDI) as a cause of new or worsening diarrhea — most often in healthcare settings after antibiotic exposure.
| Clinical Indication | What the Test Answers | Nursing Rationale |
|---|---|---|
| New unexplained diarrhea after antibiotic therapy | Could toxigenic C. difficile be driving watery stools and cramping? | providers order C. diff testing when diarrhea may be caused by antibiotics that disrupt normal colon bacteria. public health guidance defines clinically significant diarrhea as three or more unexplained unformed stools in 24 hours before testing. |
| Healthcare-associated diarrhea with leukocytosis or fever | Does the patient meet institutional diarrheal criteria for CDI testing? | CAP laboratory guidance recommends limiting testing to patients with at least three loose stools in 24 hours and documenting stool characteristics before collection. |
| Suspected pseudomembranous colitis or severe CDI physiology | Are abdominal pain, distension, or rising WBC accompanying diarrhea? | Positive toxin with compatible examination may support CDI causing colitis; severe findings require urgent escalation independent of final algorithm timing. |
| Not indicated: test-of-cure or asymptomatic surveillance | Is repeat testing being requested only because treatment ended? | public health guidance, CAP, and ASM guidance advise against test-of-cure and repeat testing within about seven days of a prior positive — nurses should clarify inappropriate orders. |
Contraindications and Precautions
Do not submit formed stool, asymptomatic patients, or routine post-treatment test-of-cure specimens per CDC and CAP guidance. Swab specimens are not appropriate for C. difficile toxin testing per ASM recommendations.
- Positive toxin with abdominal distension, hypoactive bowel sounds, or severe pain — suspect ileus or toxic megacolon; notify prescriber urgently per facility policy.
- Rising leukocytosis, hypotension, or acute kidney injury with ongoing diarrheal CDI — escalate for severe CDI evaluation and monitoring.
- Suspected CDI with precautions not initiated — begin contact precautions and hand hygiene with soap and water per infection prevention policy while awaiting results.
- CDC guidance C. difficile toxin degrades at room temperature and may be undetectable within about two hours — delayed or unrefrigerated specimens cause false negatives.
- Toxin EIA has limited sensitivity as a standalone test per ASM and standard clinical references — negative toxin does not always rule out CDI when suspicion remains.
- Testing formed stool or test-of-cure specimens produces misleading results — laboratories may reject inappropriate samples per CAP guidance.
- Positive toxin with fever, leukocytosis, dehydration, or hemodynamic changes.
- Severe abdominal distension, decreased bowel sounds, or bloody stools during CDI workup.
- Negative toxin with worsening diarrhea and recent high-risk antibiotics — notify prescriber; multistep or repeat testing may be indicated per laboratory algorithm.
Patient Preparation
Preparation focuses on verifying diarrheal criteria, documenting stool characteristics, reviewing laxatives and antibiotics, and planning prompt refrigerated transport.
Pre-test checksReview recent broad-spectrum antibiotics, proton pump inhibitors, and chemotherapy agents that increase CDI risk. Review laxatives and stool softeners — patients should not be on routine laxatives within 48 hours before testing per CAP order-screening recommendations. Nurses clarify with prescriber when antimicrobials may be adjusted after positive toxin, but do not stop prescribed therapy independently.
Performance — nursing procedure guide
This page is a Tests & Diagnostics guide for Clostridioides difficile Toxin Assay. It emphasizes why the test is ordered, how to interpret results, when to escalate, and preparation factors that affect validity — not step-by-step performance technique (those live under Nursing Procedures when available).
Step-by-step technique, supplies, infection prevention, and immediate post-procedure monitoring for this test are covered in:
Use the Patient preparation, Results and interpretation, and Nursing responsibilities sections on this page for order verification, pre-analytic checks, result follow-up, critical-value escalation, and documentation.
Result follow-up at a glance
Nursing workflow on this page — from order to safe action on results:
Results and Interpretation
Results are reported as toxin not detected (negative) or toxin detected (positive) per laboratory method. Many sites use multistep algorithms — for example GDH or NAAT with confirmatory toxin EIA. a negative toxin test alone may not rule out infection if the specimen was not kept cool or when only toxin EIA is used without companion assays.
Reference ranges, critical values, and protocols may vary by laboratory, institution, patient population, and testing method. Always follow local policy and the reporting laboratory’s reference range.
| Result | Range / Finding | Clinical Meaning | Nursing Action |
|---|---|---|---|
| Negative / not detected | Negative / toxin not detected per reporting laboratory | No C. difficile toxin A and/or B detected in submitted stool specimen | Does not completely exclude CDI if diarrhea continues — prescriber may review algorithm components, repeat testing, or alternate diagnoses; continue monitoring |
| Equivocal / borderline | Equivocal / indeterminate or partial algorithm result pending reflex testing | May reflect GDH-positive/toxin-negative pattern requiring NAAT or toxigenic culture reflex per ASM two-step algorithms | Track reflex results; notify prescriber per policy; maintain precautions if CDI still suspected clinically |
| Positive / elevated | Positive / toxin detected (toxin A and/or B EIA positive) | Toxins detected in stool — may indicate active CDI when diarrhea and examination align; this can cause pseudomembranous colitis | Notify prescriber; initiate or continue contact precautions; support CDI treatment orders (for example oral vancomycin or fidaxomicin per prescriber and severity pathway); monitor hydration and abdominal status |
| Not applicable / below detection limit | Not applicable — qualitative toxin assay | Not applicable | Not applicable |
Positive Toxin Assay and Severe CDI Response
Institution-specific critical reporting rules vary. Positive toxin with signs of severe CDI — marked leukocytosis, hypotension, abdominal distension, or acute kidney injury — requires urgent nursing assessment and prescriber notification according to facility policy, not only routine result filing.
| Critical Finding | Threshold / Value | Immediate Action |
|---|---|---|
| Positive toxin with severe abdominal findings | Toxin detected with distension, decreased bowel sounds, severe pain, or suspected ileus | Urgent prescriber and surgical/colorectal notification per protocol; NPO and monitoring as ordered; prepare for imaging escalation |
| Positive toxin with systemic deterioration | Toxin positive with fever, WBC greater than 15 × 10⁹/L, hypotension, or oliguria | Escalate per severe CDI pathway; support IV fluids, antimicrobial orders, and continuous clinical monitoring |
| Negative toxin with high clinical suspicion | Toxin not detected but diarrhea worsens on broad-spectrum antibiotics with rising WBC | Notify prescriber; verify specimen handling and timing; discuss repeat or algorithm reflex testing — do not dismiss CDI on one negative toxin alone |
Stop routine workflow and escalate according to facility policy when toxin is positive with severe abdominal or systemic findings, when precautions are not in place for suspected CDI, or when diarrhea worsens despite negative toxin on improperly handled specimens.
Factors Affecting Results
C. difficile toxin assay accuracy depends on appropriate patient selection, specimen quality, and laboratory method. Document factors that may cause false positives or false negatives.
- Testing formed stool or asymptomatic carriers — may detect colonization without active CDI
- Use of stool transport media — may increase false-positive results per public health guidance
- Standalone highly sensitive NAAT without toxin confirmation — may detect colonization; institutional algorithms aim to reduce this misinterpretation
- Toxin degradation from room-temperature storage — CDC guidance toxin may be undetectable within about two hours without refrigeration
- Toxin EIA limited sensitivity as standalone test per ASM — negative toxin may miss some CDI
- Inappropriate test timing (test-of-cure) when toxins have cleared but patient still recovering
- Recent laxatives or stool softeners within 48 hours
- Delayed transport without refrigeration
- Recent antibiotics altering stool flora but not yet causing toxin production
No single assay is perfect. In practice, toxin tests may be combined with NAAT or GDH assays because toxin alone may be falsely negative if the sample warms, and highly sensitive molecular tests may detect colonization. public health guidance advises against test-of-cure. Nurses interpret results with stool frequency, examination, and trends — not the line alone.
Nursing Responsibilities
Nursing responsibilities center on appropriate testing criteria, valid stool collection, contact precautions, result follow-up, and escalation when severe CDI signs appear.
Before the TestDocumentation
Documentation should support appropriate testing, infection prevention, and severe CDI escalation.
“Six watery stools in past 24 h documented; no laxatives since yesterday. Stool specimen collected 1035 in clean container without transport media; refrigerated and sent to lab by 1045. Contact precautions initiated 1040 for suspected CDI on ceftriaxone day 5. Toxin B EIA positive 1430 — Dr. Nguyen notified with read-back; oral vancomycin started per order; stool count and abdominal exam q4h ordered.”
- Stool frequency, consistency, and diarrheal criteria met (yes/no)
- Recent antibiotics, laxatives, and proton pump inhibitor use
- Collection time, container type, refrigeration/transport timing
- Toxin result and any reflex NAAT/GDH components with read-back
- Contact precautions start/stop and infection prevention notifications
- Treatment response, hydration status, and rationale if repeat testing declined
Patient and Family Education
Use clear language: the test checks whether C. difficile toxins are in the stool causing diarrhea. Results may take several hours depending on the laboratory method.
Clostridioides difficile Toxin Assay NCLEX practice questions
Practice NCLEX-style clinical judgment focused on Clostridioides difficile Toxin Assay safety and nursing judgment. Use the case tabs (orders, results, assessment, nursing notes), then answer eight Next Gen–style items (including an ordered workflow step) and evaluate outcomes with the answer key.
Select a tab to view orders, results, assessment, and nursing note details for this case.
- Order: C. difficile toxin assay (stool) — nurse-initiated after diarrheal criteria met
- Indication: Five watery stools in 24 h on hospital day 4 of IV ceftriaxone
- Timing: Stool collected 0940; laboratory algorithm includes toxin B EIA
- Related orders: CBC shows WBC 16.2 × 10⁹/L; BMP ordered; oral vancomycin not yet started
- Result: Toxin B EIA positive at 1345; GDH positive; NAAT component pending per lab protocol
- Trend / prior value: Stool frequency 4 → 6 per shift; mild cramping unchanged; afebrile
- Pending tests: NAAT reflex and final consolidated report pending; no test-of-cure ordered
- Vital signs: Temp 37.6°C, HR 96/min, BP 118/68, RR 18, SpO₂ 97% on room air
- Symptoms: Lower abdominal cramping, urgency, no reported blood in stool
- Focused assessment: Abdomen soft with mild diffuse tenderness; bowel sounds active; mucous membranes moist
- Preparation notes: No laxatives in 48 h documented; diarrheal criteria met; patient taught clean-container technique
- Collection events: Specimen in clean container without transport media; refrigerated at 0945; sent to lab by 1000
- Teaching gaps / safety concerns: Contact precautions not yet initiated; roommate in semi-private room; positive toxin needs team notification
Answer key & rationale
Frequently Asked Questions
FAQ
When should C. difficile toxin testing be ordered?
CDC guidance recommends testing only patients with clinically significant diarrhea — typically three or more unexplained unformed stools in 24 hours. the test is used when diarrhea may be caused by antibiotic-associated C. difficile overgrowth.
Do patients need to fast before stool toxin testing?
No fasting is required. Nurses should verify diarrheal criteria, review laxative use in the past 48 hours, and collect unformed stool promptly per laboratory instructions.
What does a positive C. difficile toxin result mean?
A positive result means toxin A and/or B was detected in the stool sample. this may indicate C. difficile infection causing diarrhea when clinical findings align. Treatment and precautions are directed by the prescriber and infection prevention team.
Can a negative toxin result rule out C. difficile infection?
Not always. In practice, toxin may degrade if the specimen is not kept cool, and toxin EIA has limited sensitivity as a standalone test. Laboratories may use multistep algorithms; persistent symptoms require prescriber review.
Should nurses repeat toxin testing after treatment ends?
CDC and CAP guidance advise against routine test-of-cure. Patients may remain test-positive while clinically improved. Repeat testing is generally limited by institutional intervals after a prior positive — nurses clarify inappropriate repeat orders.
How should stool specimens be handled?
Collect unformed stool in a clean watertight container without transport media; transport promptly and refrigerate at 2–8 °C if testing is delayed per public health guidance and public health guidance. Do not freeze specimens.
When should nurses escalate C. difficile toxin results?
Escalate according to facility policy when toxin is positive with severe abdominal findings, rising leukocytosis, hypotension, dehydration, or when contact precautions are not in place. Also escalate worsening diarrhea with negative toxin if specimen handling may be invalid.
References
References
-
U.S. National Library of Medicine. C. diff Testing. MedlinePlus Medical Test.https://medlineplus.gov/lab-tests/c-diff-testing/
-
U.S. National Library of Medicine. Stool C difficile toxin. MedlinePlus Medical Encyclopedia.https://medlineplus.gov/ency/article/003590.htm
-
Centers for Disease Control and Prevention. Clinical Testing and Diagnosis for C. diff Infection. CDC.https://www.cdc.gov/c-diff/hcp/diagnosis-testing/index.html
-
Centers for Disease Control and Prevention. Strategies to Prevent Clostridioides difficile Infections in Acute-Care Hospitals: 2022 Update. CDC.https://www.cdc.gov/infection-control/hcp/cdi/strategies-prevent-clostridioides-difficile-infections.html
-
College of American Pathologists. Clostridioides (Clostridium) difficile Testing. CAP laboratory improvement module.https://documents.cap.org/documents/ClostridiffTesting.FullModule2.0.13APR23.pdf
-
American Society for Microbiology. A Practical Guidance Document for Laboratory Detection of Clostridioides difficile. ASM.https://asm.org/asm/media/policy-and-advocacy/guidance_laboratory_detection_cdif.pdf
-
McDonald LC; Gerding DN; Johnson S; et al. Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update. Infect Control Hosp Epidemiol. 2018;39(2):158-167.https://pubmed.ncbi.nlm.nih.gov/29148204/
-
Minnesota Department of Health. C. difficile Testing — Toolkit for Long-term Care Facilities. MDH.https://www.health.state.mn.us/diseases/cdiff/hcp/ltctoolkit/testing.html
Editorial Standards & Medical Review
About the author: Sid A. Abdala Balal, RN, writes evidence-based nursing education focused on diagnostic safety, clinical interpretation, and bedside nursing judgment.
Medical review: This guide is reviewed by Dr. Adam Sayedi, MD, for clinical accuracy, diagnostic safety, and alignment with current standards for Clostridioides difficile Toxin Assay.
Policies: Medical Review Process · Editorial Policy · Correction Policy